申请人:High Point Pharmaceuticals, LLC
公开号:EP2239012A2
公开(公告)日:2010-10-13
The use of substituted amides for modulating the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and the use of these compounds as pharmaceutical compositions, are described. Also a novel class of substituted amides, their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds are modulators and more specifically inhibitors of the activity of 11βHSD1 and may be useful in the treatment, prevention and/or prophylaxis of a range of medical disorders where a decreased intracellular concentration of active glucocorticoid is desirable.
介绍了取代酰胺在调节 11β- 羟基类固醇脱氢酶 1 型(11βHSD1)活性方面的用途,以及这些化合物作为药物组合物的用途。此外,还介绍了一类新型取代酰胺、它们在治疗中的用途、包含这些化合物的药物组合物以及它们在制造药物中的用途。本化合物是 11βHSD1 活性的调节剂,更具体地说是抑制剂,可用于治疗、预防和/或预防一系列需要降低细胞内活性糖皮质激素浓度的疾病。